WallStSmart
NBY

NovaBay Pharmaceuticals Inc

NYSE MKT: NBY · HEALTHCARE · BIOTECHNOLOGY

$1.95
+22.64% today

Updated 2026-04-02

Market cap
$51.92M
P/E ratio
P/S ratio
0.16x
EPS (TTM)
$-28.50
Dividend yield
52W range
$1 – $100
Volume
1.3M

NovaBay Pharmaceuticals Inc (NBY) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Total assets$3.56M$11.87M$23.92M$13.97M$17.52M$15.52M$15.96M$19.23M$15.65M$7.54M$5.08M$15.38M$10.08M$9.36M$11.22M$15.24M$23.98M$16.40M$9.03M$3.42M
Cash & equivalents$2.21M$4.90M$10.94M$12.10M$10.99M$11.53M$8.43M$12.73M$10.50M$5.43M$2.38M$9.51M$3.20M$3.18M$6.94M$11.95M$7.50M$5.36M$3.13M$430000.00
Current assets$3.29M$11.31M$22.77M$12.51M$15.61M$13.75M$14.56M$18.28M$14.79M$6.95M$4.53M$14.47M$8.99M$8.61M$9.38M$14.24M$13.17M$11.33M$7.15M$1.94M
Total liabilities$310000.00$10.05M$9.60M$6.62M$4.18M$5.03M$6.62M$5.19M$7.13M$5.69M$10.18M$8.28M$7.49M$4.41M$10.25M$2.92M$13.81M$5.84M$5.72M$3.55M
Current liabilities$310000.00$3.39M$4.58M$4.48M$4.04M$2.72M$2.84M$3.17M$3.63M$3.35M$4.63M$4.32M$4.98M$3.85M$5.69M$2.83M$3.44M$4.26M$4.28M$2.84M
Long-term debt$546000.00$477000.00$106000.00$0.00$0.00$0.00$0.00$1.66M$0.00$0.00
Shareholder equity$3.25M$1.81M$14.32M$7.34M$13.35M$10.49M$9.34M$14.05M$8.52M$1.85M$-5.10M$7.10M$2.59M$4.95M$973000.00$12.32M$10.17M$10.55M$3.31M$-129000.00
Retained earnings$-7.79M$-13.07M$-18.47M$-26.59M$-23.89M$-28.20M$-33.28M$-40.31M$-56.35M$-71.55M$-90.52M$-103.67M$-111.07M$-114.98M$-125.02M$-136.06M$-141.89M$-158.15M$-174.85M$-183.46M
Accounts receivable$3.80M$500000.00$3000.00$943000.00$784000.00$273000.00$536000.00$2.29M$3.71M$3.49M$1.07M$1.11M$1.69M$2.02M$759000.00$389000.00
Inventory$0.00$23000.00$231000.00$521000.00$1.34M$873000.00$504000.00$280000.00$492000.00$608000.00$3.22M$3.44M$2.88M$765000.00
Goodwill$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.53M$348000.00$0.00